Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Why ResMed Stock Tumbled by 5% Today
Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost more than 5% of their value on news of an analyst's downgrade and his new, bearish outlook.
ResMed Inc. stock rises Friday, outperforms market
Shares of ResMed Inc. RMD inched 0.81% higher to $244.94 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.09% to 42,
Stock of the day: ResMed
ResMed faces a 3% drop in share price after concerns over Eli Lilly’s Ozempic, which could impact the demand for CPAP machines in the sleep apnea market.
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
ResMed RMD has outperformed the market over the past 15 years by 5.67% on an annualized basis producing an average annual return of 17.22%. Currently, ResMed has a market capitalization of $35.98 billion.
ResMed Inc. stock falls Wednesday, underperforms market
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top
Why ResMed Stock Tumbled by 5% Today
Healthcare technology company
ResMed
's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost more than 5% of their value on
news
of an analyst's downgrade and his new ...
Why is the ResMed share price taking a thumping on Thursday?
Investors seem to be signalling out ResMed for punishment. The post Why is the ResMed share price taking a thumping on Thursday? appeared first on The Motley Fool Australia.
4d
on MSN
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
4d
ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of Safety
ResMed achieved double-digit revenue growth through acquisitions and operating efficiencies, with improving capital ...
bovnews
3d
Resmed Inc (RMD) Stock Settles at $238.03: What’s Contributing to This Price Point?
Wolfe Research has recently reduced Resmed Inc (RMD) stock to Underperform rating, as announced on September 18, 2024, according to Finviz. Earlier, on September 4, 2024, Needham had reduced the stock ...
4d
on MSN
Top Stock Movers Now: US Steel, VF Corp., ResMed, and More
Major U.S. indexes were little changed at midday Wednesday, ahead of the Federal Reserve's decision on interest rates.
4d
Why ResMed's Rally Is Just Getting Started
ResMed's AirSense 11 platform and myAir app enhance patient engagement and efficiency. Check out why I remain bullish on RMD ...
4d
ResMed Faces Market Disruption and Limited Growth: A Sell Rating Analysis
Wolfe Research analyst Michael Polark downgraded the rating on Resmed (RMD – Research Report) to a Sell yesterday, setting a price target ...
15h
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 74%
To get a sense of who is truly in control of ResMed Inc. ( NYSE:RMD ), it is important to understand the ownership structure ...
4d
on MSN
S&P 500 Gains and Losses Today: ResMed Drops as Weight-Loss Drugs Threaten Demand
Key Takeaways The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, as the Federal Reserve announced its first interest-rate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
New York Stock Exchange
Intuitive Machines
Super Micro
S&P 500 Index
General Mills
Feedback